Acquisition by Chaim Lebovits of 22000 shares of Brainstorm Cell at 0.228 subject to Rule 16b-3
BCLI Stock | USD 1.58 0.04 2.60% |
Under 55% of Brainstorm Cell's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that some traders are interested. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
Brainstorm |
Filed transaction by Brainstorm Cell Therapeutics Officer: President & Ceo. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Brainstorm Cell Fundamental Analysis
We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Brainstorm Cell is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Brainstorm Cell Ther Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.
Peers
Brainstorm Cell Related Equities
XFOR | X4 Pharmaceuticals | 8.11 | ||||
HOWL | Werewolf Therapeutics | 6.90 | ||||
BCAB | Bioatla | 6.45 | ||||
CKPT | Checkpoint Therapeutics | 5.54 | ||||
CCCC | C4 Therapeutics | 4.23 | ||||
ANTX | AN2 Therapeutics | 2.70 | ||||
HCWB | HCW Biologics | 2.70 | ||||
CRVS | Corvus Pharmaceuticals | 2.54 | ||||
PASG | Passage Bio | 1.96 | ||||
CNTB | Connect Biopharma | 1.11 | ||||
TRVI | Trevi Therapeutics | 0.44 | ||||
CELC | Celcuity LLC | 0.74 | ||||
CUE | Cue Biopharma | 0.81 | ||||
EWTX | Edgewise Therapeutics | 0.83 | ||||
INZY | Inozyme Pharma | 0.83 | ||||
GRI | GRI Bio | 0.88 | ||||
TERN | Terns Pharmaceuticals | 1.86 | ||||
PLX | Protalix Biotherapeutics | 2.10 | ||||
MREO | Mereo BioPharma | 2.78 | ||||
GBIO | Generation Bio | 3.57 | ||||
DAWN | Day One | 4.03 | ||||
ALDX | Aldeyra | 19.40 |
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |